Life sciences innovator Unchained Labs has launched the AI Developability Workcell, an integrated platform that combines automation, sample preparation, purpose-built analytics, and native artificial intelligence to streamline biologics candidate selection. Built upon the company’s Stuntman automation platform, the workcell combines analytical instruments including Stunner for concentration and sizing, Aunty for thermal and colloidal stability, and Lil’ Tuna for buffer exchange directly on a single deck to screen candidate plates in one unified location. By eliminating manual sample handoffs, fragmented software systems, and piecemeal data aggregation, the solution enables drug discovery teams to execute comprehensive developability experiments, evaluate candidate viability, and accelerate candidate selection from weeks to days.
Also Read: Guardant Health Earns FDA Approval for Guardant360 CDx
Highlighting the shift away from legacy workflows, Tim Harkness, Founder and CEO of Unchained Labs, stated: “Developability research has been stuck in the past samples moving from tool to tool, data trapped in different software and scientists left to piece together the answer. The AI Developability Workcell changes all of that. Automation, sample prep, analytics and AI work together from day one so teams can ditch the chaos, stop chasing data and start advancing the right candidates in days instead of weeks.” Ultimately, this platform-native workcell provides biopharmaceutical research organizations with an end-to-end, automated ecosystem that maximizes sample efficiency, standardizes structured data generation, and optimizes early-stage biologic drug development.